Literature DB >> 191549

Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits.

A C Ross, D B Zilversmit.   

Abstract

Feeding rabbits 500 mg of cholesterol daily for 4 to 15 days greatly increased the concentration of esterified cholesterol in lipoproteins of d less than 1.006 g/ml. The origin of hypercholesterolemic very low density lipoproteins was investigated by monitoring the degradation of labeled lymph chyomicrons administered to normal and cholesterol-fed rabbits. Chylomicrons were labeled in vivo by feeding either 1) [3H]cholesterol and [14C]oleic acid or 2) [14C]cholesterol and [3H]retinyl acetate. After intravenous injection of labeled chylomicrons to recipient rabbits, [14C]triglyceride hydrolysis was equally rapid in normal and cholesterol-fed animals. Normal rabbits rapidly removed from plasma both labeled cholesteryl and retinyl esters, whereas cholesterol-fed rabbits retained nearly 50% of doubly labeled remnants in plasma 25 min after chylomicron injection. Ultracentrifugal separation of plasma into subfractions of very low density lipoproteins showed that chylomicron remnants in cholesterol-fed animals are found among all subclasses of very low density lipoproteins. Analysis of cholesteryl ester specific activity-time curves for the very low density lipoproteins subfraction from hypercholesterolemic plasma showed that nearly all esterified cholesterol in large very low density lipoproteins and approximately 30% of esterified cholesterol in small very low density lipoproteins was derived from chylomicron degradation. Apparently, nearly two-thirds of the esterified cholesterol in total very low density lipoproteins from moderately hypercholesterolemic rabbits is of dietary origin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191549

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Profile of A. Catharine Ross.

Authors:  Bijal Trivedi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

2.  Studies on the structure of low density lipoproteins isolated from Macaca fascicularis fed an atherogenic diet.

Authors:  A R Tall; D M Small; D Atkinson; L L Rudel
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

3.  Oral vitamin A and retinoic acid supplementation stimulates antibody production and splenic Stra6 expression in tetanus toxoid-immunized mice.

Authors:  Libo Tan; Amanda E Wray; A Catharine Ross
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

4.  Cellular and subcellular distribution of 125I-labeled very low density lipoproteins in the liver of normal and estrogen-treated rabbits.

Authors:  R V Iozzo; R S Kushwaha; T N Wight; W R Hazzard
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

5.  Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits.

Authors:  G Xu; G Salen; S Shefer; G C Ness; L B Nguyen; T S Parker; T S Chen; Z Zhao; T M Donnelly; G S Tint
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Very low density lipoprotein secretion by cultured hepatocytes of rabbits fed purified or autoxidized cholesterol.

Authors:  V A Kosykh; V Z Lankin; E A Podrez; D K Novikov; S A Volgushev; A V Victorov; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1989-02       Impact factor: 1.880

7.  Isolation and characterization of hepatic Golgi lipoproteins from hypercholesterolemic rats.

Authors:  L L Swift; N R Manowitz; G D Dunn; V S LeQuire
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

8.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.

Authors:  D L Sprecher; S L Knauer; D M Black; L A Kaplan; A A Akeson; M Dusing; D Lattier; E A Stein; M Rymaszewski; D A Wiginton
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.